Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. El-Merhie (Borstel, Germany), M. Wolff (Borstel, Germany), C. Ruppert (Giessen, Germany), A. Günther (Giessen, Germany), P. Hansbro (Sydney, Australia), T. Goldmann (Borstel, Germany), S. Krauss-Etschmann (Borstel, Germany). Lipocalin-2: a biomarker potentially associated with predisposition to COPD. 609

Member's Comments

No comment yet.

Related content which might interest you: Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD Source: Eur Respir J 2014; 43: 951-953 Year: 2014 Microalbuminuria as a cardiovascular biomarker in patients with COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 DNA-estimated ageing markers are associated with COPD Source: International Congress 2018 – Role of omics in population studies Year: 2018 Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019 Leptin as a specific marker of risk factors in severe bronchial asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 COPD Source: Respipedia Article Year: 2018 Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate Source: Eur Respir J 2010; 35: 768-775 Year: 2010 Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005 Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021 Can YKL-40 be used as a biomarker and therapeutic target for adult asthma? Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017 Year: 2018 Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Is OSA an important risk factor for metabolic dysregulation in obese COPD patients Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Pro-surfactant protein B, a promising BAL biomarker of COPD progression in heavy smokers, is increased by budesonide/formoterol short-term therapy Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013